FINOTEN

This brand name is authorized in Estonia, Lithuania

Active ingredients

The drug FINOTEN contains a combination of these active pharmaceutical ingredients (APIs):

1 Phenazone
UNII T3CHA1B51H - ANTIPYRINE

Phenazone has analgesic and antipyretic properties. Topically, solutions have been used locally as ear drops in disorders such as otitis media because of its local anti-inflammatory and analgesic action.

Read about Phenazone
2 Lidocaine
UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.

Read about Lidocaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S02DA30 Combinations S Sensory organs → S02 Otologicals → S02D Other otologicals → S02DA Analgesics and anesthetics
Discover more medicines within S02DA30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1662779
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1074382

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.